The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease
Open accessAbstract
BACKGROUND: The level of the inactive N-terminal fragment of pro-brain (B-type) natriuretic peptide (BNP) is a strong predictor of mortality among patients with acute coronary syndromes and may be a strong prognostic marker in patients with chronic coronary heart disease as well. We assessed the relationship between N-terminal pro-BNP (NT-pro-BNP) levels and long-term mortality from all causes in a large cohort of patients with stable coronary heart disease. METHODS: NT-pro-BNP was measured in baseline serum samples from 1034 patients referred for angiography because of symptoms or signs of coronary heart disease. The rate of death from all causes was determined after a median follow-up of nine years. RESULTS: At follow-up, 288 patients had died. The median NT-pro-BNP level was significantly lower among patients who survived than among those who died (120 pg per milliliter [interquartile range, 50 to 318] vs. 386 pg per milliliter [interquartile range, 146 to 897], P<0.001). Patients with NT-pro-BNP levels in the highest quartile were older, had a lower left ventricular ejection fraction (LVEF) and a lower creatinine clearance rate, and were more likely to have a history of myocardial infarction, clinically significant coronary artery disease, and diabetes than patients with NT-pro-BNP levels in the lowest quartile. In a multivariable Cox regression model, the hazard ratio for death from any cause for the patients with NT-pro-BNP levels in the fourth quartile as compared with those in the first quartile was 2.4 (95 percent confidence interval, 1.5 to 4.0; P<0.001); the NT-pro-BNP level added prognostic information beyond that provided by conventional risk factors, including the patient's age; sex; family history with respect to ischemic heart disease; the presence or absence of a history of myocardial infarction, angina, hypertension, diabetes, or chronic heart failure; creatinine clearance rate; body-mass index; smoking status; plasma lipid levels; LVEF; and the presence or absence of clinically significant coronary artery disease on angiography. CONCLUSIONS: NT-pro-BNP is a marker of long-term mortality in patients with stable coronary disease and provides prognostic information above and beyond that provided by conventional cardiovascular risk factors and the degree of left ventricular systolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Levin, E. R., Gardner, D. G., & Samson, W. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390507 · Cited by 1,927
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
de Lemos, J. A., Morrow, D. A., Bentley, J. H., Omland, T., Sabatine, M. S., McCabe, C. H., Hall, C., Cannon, C. P., & Braunwald, E. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011053 · Cited by 1,284
Tsutamoto, T., Wada, A., Maeda, K., Hisanaga, T., Maeda, Y., Fukai, D., Ohnishi, M., Sugimoto, Y., & Kinoshita, M. (1997) · Circulation · doi:10.1161/01.cir.96.2.509 · Cited by 963
Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., & Braunwald, E. (2002) · Circulation · doi:10.1161/01.cir.0000015464.18023.0a · Cited by 735
Omland, T., Aakvaag, A., Bonarjee, V. V. S., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J. A., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 700
Richards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
Morita, E., Yasue, H., Yoshimura, M., Ogawa, H., Jougasaki, M., Matsumura, T., Mukoyama, M., & Nakao, K. (1993) · Circulation · doi:10.1161/01.cir.88.1.82 · Cited by 580
James, S. K., Lindahl, B., Siegbahn, A., Stridsberg, M., Venge, P., Armstrong, P., Barnathan, E. S., Califf, R., Topol, E. J., Simoons, M. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000079170.10579.dc · Cited by 579
Cited by
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Authors/Task Force Members (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl001 · Cited by 1,336
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Daniels, L. B., & Maisel, A. S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.021 · Cited by 952
Santos-Gallego, C. G., Requena-Ibanez, J. A., San Antonio, R., Ishikawa, K., Watanabe, S., Picatoste, B., Flores, E., Garcia-Ropero, A., Sanz, J., Hajjar, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.056 · Cited by 651
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
Weber, M. (2005) · Heart · doi:10.1136/hrt.2005.071233 · Cited by 618
Fonarow, G. C., Peacock, W. F., Phillips, C. O., Givertz, M. M., & Lopatin, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.037 · Cited by 563
Biomarkers and diagnostics in heart failure
Gaggin, H. K., & Januzzi, J. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.014 · Cited by 423
Hijazi, Z., Oldgren, J., Andersson, U., Connolly, S. J., Ezekowitz, M. D., Hohnloser, S. H., Reilly, P. A., Vinereanu, D., Siegbahn, A., Yusuf, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.038729 · Cited by 402
Cao, Z., Jia, Y., & Zhu, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081820 · Cited by 398
Di Angelantonio, E., Chowdhury, R., Sarwar, N., Ray, K. K., Gobin, R., Saleheen, D., Thompson, A., Gudnason, V., Sattar, N., & Danesh, J. (2009) · Circulation · doi:10.1161/circulationaha.109.884866 · Cited by 378
Watz, H., Waschki, B., Boehme, C., Claussen, M., Meyer, T., & Magnussen, H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1011oc · Cited by 368
Chan, K. M. J., Punjabi, P. P., Flather, M., Wage, R., Symmonds, K., Roussin, I., Rahman-Haley, S., Pennell, D. J., Kilner, P. J., Dreyfus, G. D., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.143818 · Cited by 332
Lipshultz, S. E., Miller, T. L., Scully, R. E., Lipsitz, S. R., Rifai, N., Silverman, L. B., Colan, S. D., Neuberg, D. S., Dahlberg, S. E., Henkel, J. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3404 · Cited by 323
Wilson Tang, W. H., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., Storrow, A. B., Christenson, R. H., COMMITTEE MEMBERS, Christenson, R. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.185267 · Cited by 310
Biomarkers in atrial fibrillation: a clinical review
Hijazi, Z., Oldgren, J., Siegbahn, A., Granger, C. B., & Wallentin, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht024 · Cited by 298
Natriuretic peptides in cardiovascular diseases: current use and perspectives
Volpe, M., Rubattu, S., & Burnett, J. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht466 · Cited by 277
Bibbins-Domingo, K., Gupta, R., Na, B., Wu, A. H. B., Schiller, N. B., & Whooley, M. A. (2007) · JAMA · doi:10.1001/jama.297.2.169 · Cited by 276
Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD
Chang, C. L., Robinson, S. C., Mills, G. D., Sullivan, G. D., Karalus, N. C., McLachlan, J. D., & Hancox, R. J. (2011) · Thorax · doi:10.1136/thx.2010.155333 · Cited by 265
Januzzi, J. L., Sakhuja, R., O’Donoghue, M., Baggish, A. L., Anwaruddin, S., Chae, C. U., Cameron, R., Krauser, D. G., Tung, R., Camargo, C. A., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.315 · Cited by 261
Karthikeyan, G., Moncur, R. A., Levine, O., Heels-Ansdell, D., Chan, M. T. V., Alonso-Coello, P., Yusuf, S., Sessler, D., Villar, J. C., Berwanger, O., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.028 · Cited by 260
N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation
Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., Gersh, B. J., Hanna, M., Hohnloser, S., Horowitz, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.082 · Cited by 231
N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA · doi:10.1001/jama.296.3.310 · Cited by 197
Sekhri, N., Feder, G. S., Junghans, C., Hemingway, H., & Timmis, A. D. (2007) · Heart · doi:10.1136/hrt.2006.090894 · Cited by 151
Hirata, T., Arai, Y., Yuasa, S., Abe, Y., Takayama, M., Sasaki, T., Kunitomi, A., Inagaki, H., Endo, M., Morinaga, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17636-0 · Cited by 138
Giallauria, F., Cirillo, P., Lucci, R., Pacileo, M., De Lorenzo, A., D'Agostino, M., Moschella, S., Psaroudaki, M., Del Forno, D., Orio, F., et al. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282f00990 · Cited by 99
Effects of oral appliances and CPAP on the left ventricle and natriuretic peptides
Hoekema, A., Voors, A. A., Wijkstra, P. J., Stegenga, B., van der Hoeven, J. H., Tol, C. G., & de Bont, L. G. M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.06.016 · Cited by 81
Peters, M. J. L., Welsh, P., McInnes, I. B., Wolbink, G., Dijkmans, B. A. C., Sattar, N., & Nurmohamed, M. T. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119412 · Cited by 62
Giallauria, F., Lorenzo, A. D., Pilerci, F., Manakos, A., Lucci, R., Psaroudaki, M., D'Agostino, M., Forno, D. D., & Vigorito, C. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000209810.59831.f4 · Cited by 60
Provan, S., Angel, K., Semb, A. G., Atar, D., & Kvien, T. K. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127704 · Cited by 50
Metadata
- Authors
- Kragelund, C., Grønning, B., Køber, L., Hildebrandt, P., & Steffensen, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-02-17
- Volume
- 352
- Issue
- 7
- Pages
- 666-675
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1997808420
- Cited by
- 631
- References
- 25
- FWCI
- 46.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.